Agilent to buy Proscia for $240M
The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo